Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glycocalyx and magnesium in delayed cerebral ischemia after subarachnoid hemorrhage
NL-OMON35997Withdrawn
- Sponsor
- Amsterdam University Medical Center
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of magnesium sulfate in subarachnoid hemorrhage (SAH), sponsored by Amsterdam University Medical Center. Primary endpoint: Endothelial glycocalyx alteration after SAH and in DCI. Status: withdrawn.
02
Drugs
magnesium sulfate
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NL-OMON35997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35997.